The Global Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027. The extensive proliferation of the minimally invasive surgical technologies and extensive rise in the requirement of biopsy tests to diagnose cancerous cells and identifying infectious, autoimmune disorders and inflammatory cases. Early detection of the cancers and higher precision compared to incisional and excisional biopsies have been the constant driving factors for this market.

Considerable numbers of the overall open excisional biopsy have been replaced by the minimally invasive biopsy technology in patients having the imaging-detected suspicious or the indeterminate breast lesions. With minimally invasive surgeries in the biopsy, higher precisions can be accumulated, which in turn helps in reducing the psychological burden that affects the patients and also helps reduce the overall cost by a significant margin.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/75

Further key findings from the report suggest

• The ambulatory surgery centers have a more convenient outpatient procedure alternative to the hospital-based inpatient systems, maintaining a strong track record of quality care. Ambulatory surgery centers, incorporating all the required and modern MIB technologies, are expected to grow fastest amongst the end-use verticals throughout the forecast period.
• The therapeutic application is further segmented into Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, and Non-oncology Application. Minimally invasive breast biopsy (MIBB) has been highly recommended for the pre breast cancer diagnosis and checkup globally. The MIBB is expected to grow higher during the projected period as the number of breast cancer increases.
• Key players in the market include Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, and Owlstone Medical Ltd., among others.

Minimally Invasive Biopsy Technologies Market Segmentation:

For the purpose of this report, Emergen Research has segmented into the global Minimally Invasive Biopsy Technologies Market on the basis of Technology, Therapeutic Application, End-Use Verticals, and region:

• Technology Outlook (Revenue: USD Billion; 2017-2027)
  • Liquid Biopsy
  • Optical Biopsy
  • Brush Biopsy
  • Pigmented Lesion Assays
  • Breath Biopsy
  • Brush Biopsy
  • Others
• Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Blood Cancer
  • Non-oncology Applications
• End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Others

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, AsiaPacific, and Middle East & Africa.In conclusion, the research report on the Minimally Invasive Biopsy Technologies market assesses growth prospects, opportunities, challenges, risks, threats, and trends to offer a comprehensive idea of the regional and global Minimally Invasive Biopsy Technologies market.

Request a customized copy of the Minimally Invasive Biopsy Technologies market report @ https://www.emergenresearch.com/request-for-customization/75

Key highlights of the report:

• The latest report performs an in-depth study of the potential opportunities and risks associated with the global Minimally Invasive Biopsy Technologies market, alongside studying the recent innovations and major events.
• The report underlines the niche segments/regions that exhibit potential growth over the forecast timeframe.
• The report analyzes numerous business expansion strategies adopted by the contending companies in this market.
• A detailed synopsis of the market includes the rapidly changing market dynamics and accurate prediction of the current, historical, and forecast market sizes in terms of volume and value.

Table Of Content:

Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Minimally Invasive Biopsy Technologies Market Segmentation & Impact Analysis
    4.1. Minimally Invasive Biopsy Technologies Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                    4.2.2.1. Increasing proliferation of the minimally invasive surgical procedure
                    4.2.2.2. Extensive rise in the cancers & biopsy testing
                    4.2.2.3. Minimum hospitalization for biopsy testing
          4.2.3. Market restraints analysis
                    4.2.3.1. Unavailability of the skilled professional
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. Porter’s Five Forces Analysis
    4.6. Competitive Metric Space Analysis
    4.7. Price trend Analysis
    4.8. Covid-19 Impact Analysis

READ MORE…!

Gain access to the full report by clicking here on the link @ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market

Thank you for reading our report. Customization of this report is available as per client requirements. Please connect with us to know more about the report, and our team will ensure you get the report tailored according to your needs.

Have a Look at Related Reports:

Autoinjectors Market@ https://www.emergenresearch.com/industry-report/autoinjectors-market

Blockchain Supply Chain Market@ https://www.emergenresearch.com/industry-report/blockchain-supply-c...

Non-Volatile Memory Express (NVMe) Market@ https://www.emergenresearch.com/industry-report/non-volatile-memory...

IoT in Education Market@ https://www.emergenresearch.com/industry-report/iot-in-education-ma...

Hemodynamic Monitoring Devices Market@ https://www.emergenresearch.com/industry-report/hemodynamic-monitor...

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs